Open-label single-arm, multicenter clinical trial to evaluate patient acceptability of a new CREON formulation of Pancreas Powder gastro-resistant pellets in patients with cystic fibrosis suffering from pancreatic exocrine insufficiency. - PANC-GRP-3001
Latest Information Update: 19 Jan 2026
At a glance
- Drugs Pancrelipase (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Sponsors Meda Pharma GmbH & Co KG
Most Recent Events
- 19 Jan 2026 New trial record